Amgen's Q4 results showed, again, how dependent the company is on the FDA coming up with a solid approval for denosumab, its osteoporosis drug. Revenues were down a little bit to $3.6 billion, but ...
Amgen's Q4 results showed, again, how dependent the company is on the FDA coming up with a solid approval for denosumab, its osteoporosis drug. Revenues were down a little bit to $3.6 billion, but ...
The high cost of prescription drugs is a hot topic in the U.S., a factor likely on the minds of Amgen executives in setting the price of a new treatment for migraine headaches.
amgen scholars us symposium free download - Eighth Annual US Hedge Fund Symposium, Symposium Cracoviense - Meetings & Events, MyItinerary by ScholarOne, and many more programs
A man claims his former beauty queen and news anchor wife is dangerously dependent on Adderall and doesn't sleep, has severe panic attacks and often rambles. She says she loves the drug and all the “magical” things it’s doing for her life.
Still, the stock posted strong gains Wednesday based on positive comments by analysts. As of 11 a.m. ET, the stock was up nearly $3 a share, or 3 percent, to $97.50.
Many templates and web forms use Word form fields to solicit information from the user. Occasionally, the selection in one field determines the contents of another. You can hard-code list items in ...